MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Long-term Outcomes with Established Therapies
In this podcast, expert clinicians will revisit an important topic from MS ForumĀ® VIII, the use of current and emerging oral therapies for MS, including the Burtonās tyrosine kinase (BTK) inhibitors.
In this podcast, expert clinicians will discuss best practices for early recognition and diagnosis of relapsing MS and recent evidence in treatment options in this setting.
In this podcast, expert clinicians will discuss the clinical data of new and emerging therapies for MS and their potential role in the current treatment algorithm.
In this podcast, expert clinicians will discuss the future treatment of Alzheimerās disease, examining mechanisms of action and clinical trial data for emerging agents.
In this podcast, expert clinicians will discuss the current available therapies for Alzheimerās disease and the strengths and weaknesses of these therapies.
In this podcast, expert clinicians will discuss the pathological hallmarks of Alzheimerās disease and how to differentiate Alzheimerās from other dementias.
In this podcast, expert clinicians will discuss the importance of early diagnosis in Alzheimerās disease and assessment tools for making an early diagnosis.
In this podcast, Patricia K. Coyle, MD, and Clyde E. Markowitz, MD, discuss shared decision-making strategies to engage patients with MS in their own care.